Adjuvant Radiotherapy in Breast Cancer: Consideration of Cost-Benefits in Relation to the CRC (King's/Cambridge) Trial
Published online by Cambridge University Press: 10 March 2009
Extract
The Cancer Research Campaign (CRC) Trial demonstrates a decreased incidence of local recurrence for patients randomized to prophylactic radiotherapy following mastectomy. Irradiated patients alive after 5 years, however, have a small increased risk of dying from causes other than breast cancer. How to estimate the cost-benefit of such therapy is discussed.
- Type
- Special Section: Technology Assessment and Surgical Policy
- Information
- International Journal of Technology Assessment in Health Care , Volume 5 , Issue 3 , July 1989 , pp. 415 - 422
- Copyright
- Copyright © Cambridge University Press 1989
References
REFERENCES
- 2
- Cited by